BNP Paribas Asset Management’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-72,106
Closed -$15.4M 2262
2025
Q4
$15.4M Sell
72,106
-117,548
-62% -$24.3M 0.02% 581
2025
Q3
$37.7M Sell
189,654
-87,330
-32% -$16.3M 0.1% 224
2025
Q2
$47.8M Sell
276,984
-53,169
-16% -$8.66M 0.12% 181
2025
Q1
$51.5M Buy
330,153
+13,573
+4% +$1.94M 0.14% 153
2024
Q4
$43.6M Buy
316,580
+72,724
+30% +$9.56M 0.11% 199
2024
Q3
$36.4M Buy
243,856
+80,746
+50% +$10.9M 0.09% 226
2024
Q2
$22.2M Buy
163,110
+76,908
+89% +$10.5M 0.06% 274
2024
Q1
$13M Buy
+86,202
New +$12.3M 0.03% 386
2022
Q3
Sell
-6,729
Closed -$626K 903
2022
Q2
$626K Buy
+6,729
New +$634K ﹤0.01% 829

Other funds holding ASND